![designer491-3](https://cdn.lifesciencesipreview.com/convert/files/2023/08/f2b13d70-4113-11ee-8179-0f0ce8051b03-designer491-3.jpg/r%5Bwidth%5D=320/f2b13d70-4113-11ee-8179-0f0ce8051b03-designer491-3.webp)
designer491 / iStockphoto.com
29 January 2018Big Pharma
Sanofi to acquire Ablynx for €3.9bn
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
2 February 2018 Seattle Genetics has announced that it will acquire biotech company Cascadian Therapeutics for approximately $614 million.
Europe
19 April 2018 France-based Sanofi has confirmed it is in negotiations to sell its European generics business Zentiva for €1.9 billion ($2.4 billion) to private equity firm Advent International.
Americas
5 December 2018 US-based Allele Biotechnology & Pharmaceuticals, a preclinical-stage biopharmaceutical company, has teamed up with a scientific e-commerce marketplace network in efforts to develop nanoantibodies for therapeutic applications.
Editor's picks
Editor's picks
Americas
2 February 2018 Seattle Genetics has announced that it will acquire biotech company Cascadian Therapeutics for approximately $614 million.
Europe
19 April 2018 France-based Sanofi has confirmed it is in negotiations to sell its European generics business Zentiva for €1.9 billion ($2.4 billion) to private equity firm Advent International.
Americas
5 December 2018 US-based Allele Biotechnology & Pharmaceuticals, a preclinical-stage biopharmaceutical company, has teamed up with a scientific e-commerce marketplace network in efforts to develop nanoantibodies for therapeutic applications.
Americas
2 February 2018 Seattle Genetics has announced that it will acquire biotech company Cascadian Therapeutics for approximately $614 million.
Europe
19 April 2018 France-based Sanofi has confirmed it is in negotiations to sell its European generics business Zentiva for €1.9 billion ($2.4 billion) to private equity firm Advent International.
Americas
5 December 2018 US-based Allele Biotechnology & Pharmaceuticals, a preclinical-stage biopharmaceutical company, has teamed up with a scientific e-commerce marketplace network in efforts to develop nanoantibodies for therapeutic applications.